ArticleFrontiers in oncology2021

Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma.

Dylan J Martini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.